Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Equity Ratio (2019 - 2025)

BioScience Health Innovations (BHIC) has disclosed Equity Ratio for 7 consecutive years, with 0.87 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 9.47% to 0.87 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.87 through Dec 2025, down 9.47% year-over-year, with the annual reading at 0.87 for FY2025, 9.47% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.87 at BioScience Health Innovations, up from 0.83 in the prior quarter.
  • The five-year high for Equity Ratio was 0.96 in Q4 2024, with the low at 23.09 in Q2 2021.
  • Average Equity Ratio over 5 years is 1.05, with a median of 0.77 recorded in 2021.
  • The sharpest move saw Equity Ratio plummeted 69451.78% in 2021, then skyrocketed 1420.53% in 2024.
  • Over 5 years, Equity Ratio stood at 0.76 in 2021, then rose by 18.18% to 0.9 in 2022, then plummeted by 108.05% to 0.07 in 2023, then surged by 1420.53% to 0.96 in 2024, then decreased by 9.47% to 0.87 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.87, 0.83, and 0.84 for Q4 2025, Q3 2025, and Q2 2025 respectively.